Fingerprint
Dive into the research topics of 'Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
Rolf Wachter*, Sanjiv J. Shah, Martin R. Cowie, Peter Szecsödy, Victor Shi, Ghionul Ibram, Ziqiang Zhao, Jianjian Gong, Sven Klebs, Burkert Pieske
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations